None
Quote | Guerbet SA (OTCMKTS:GUERF)
Last: | $22.25 |
---|---|
Change Percent: | 0.0% |
Open: | $22.25 |
Close: | $22.25 |
High: | $22.25 |
Low: | $22.25 |
Volume: | 200 |
Last Trade Date Time: | 07/05/2022 04:36:56 am |
News | Guerbet SA (OTCMKTS:GUERF)
H1 2024 revenue Half-yearly activity H1 revenue: €419.2m, up 11.8% at CER 1 , including an acceleration in Q2 (+14.5%) This acceleration was driven by continued catch-up in the Americas, the normalisation of orders in France and MRI sales Annual targets conf...
The CHMP issues an opinion in favour of granting an EU marketing authorisation for Elucirem™ (Gadopiclenol) with the indication of use for magnetic resonance imaging with contrast enhancement in adults and children aged 2 years and over If approved by the European...
Message Board Posts | Guerbet SA (OTCMKTS:GUERF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Guerbet SA Company Name:
GUERF Stock Symbol:
OTCMKTS Market:
H1 2024 revenue Half-yearly activity H1 revenue: €419.2m, up 11.8% at CER 1 , including an acceleration in Q2 (+14.5%) This acceleration was driven by continued catch-up in the Americas, the normalisation of orders in France and MRI sales Annual targets conf...
The CHMP issues an opinion in favour of granting an EU marketing authorisation for Elucirem™ (Gadopiclenol) with the indication of use for magnetic resonance imaging with contrast enhancement in adults and children aged 2 years and over If approved by the European...
Half-year results 2023 Acceleration of activity Half-year revenue: €378.6 million, up 2.8% at CER 1 Strong acceleration of activity in the second quarter, up 6.7% at CER Profitability in line with expectations EBITDA for the first...